
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
OC-3 CRISPR/Cas9 KO Plasmid (h) | sc-406357 | 20 µg | $397.00 |
ONECUT3 encodes the transcription factor OC-3, a member of the onecut family characterized by a CUT domain and homeobox DNA-binding domain that coordinate tissue-specific gene expression programs. OC-3 contributes to regulation of cellular differentiation and lineage specification by controlling transcriptional networks that shape developmental and metabolic states. In human biology, ONECUT3 expression patterns have been linked to modulation of epithelial and hepatic gene regulatory circuitry and broader transcriptional control of organogenesis-related pathways. Dysregulated onecut-family activity has been examined in the context of altered differentiation, proliferation, and tumor-associated transcriptional reprogramming, supporting its use as a node for mechanistic studies of disease-relevant gene networks.
OC-3 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the ONECUT3 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the ONECUT3 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the ONECUT3 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish OC-3 protein expression.
This CRISPR knockout system enables efficient generation of ONECUT3-deficient cell models for investigation of OC-3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.